| related words |
| efficacy |
| vaccine |
| safer |
| xr |
| investigator |
| commercialized |
| insulin |
| compound |
| cubicin |
| endpoint |
| discovering |
| announce |
| receptive |
| collaborative |
| predictive |
| demonstrate |
| hemopure |
| hematide |
| enroll |
| myvax |
|
| related documents |
| 1087432--3/15/2010--INTERMUNE_INC |
| 1341843--3/27/2008--POLYMEDIX_INC |
| 1062216--3/28/2008--MEMORY_PHARMACEUTICALS_CORP |
| 1087432--3/14/2008--INTERMUNE_INC |
| 1087432--3/30/2007--INTERMUNE_INC |
| 1048477--2/28/2007--BIOMARIN_PHARMACEUTICAL_INC |
| 1048477--3/7/2006--BIOMARIN_PHARMACEUTICAL_INC |
| 1048477--2/26/2010--BIOMARIN_PHARMACEUTICAL_INC |
| 1048477--2/27/2009--BIOMARIN_PHARMACEUTICAL_INC |
| 1048477--2/28/2008--BIOMARIN_PHARMACEUTICAL_INC |
| 1062216--4/2/2007--MEMORY_PHARMACEUTICALS_CORP |
| 716646--6/14/2010--CLINICAL_DATA_INC |
| 1080014--2/26/2010--THERAVANCE_INC |
| 1109196--3/2/2010--TELIK_INC |
| 1285819--3/31/2010--OMEROS_CORP |
| 1235010--3/12/2010--MOMENTA_PHARMACEUTICALS_INC |
| 879169--3/5/2010--INCYTE_CORP |
| 1260990--3/15/2010--GTX_INC_/DE/ |
| 1208261--3/15/2010--EPICEPT_CORP |
| 907562--3/12/2010--DYAX_CORP |
|
| related topics |
| {product, candidate, development} |
| {tax, income, asset} |
| {cost, regulation, environmental} |
| {cost, contract, operation} |
| {regulation, government, change} |
| {product, liability, claim} |
| {customer, product, revenue} |
| {system, service, information} |
| {condition, economic, financial} |
| {property, intellectual, protect} |
| {capital, credit, financial} |
| {operation, international, foreign} |
| {provision, law, control} |
| {financial, litigation, operation} |
| {operation, natural, condition} |
| {cost, operation, labor} |
| {competitive, industry, competition} |
| {gas, price, oil} |
| {control, financial, internal} |
| {product, market, service} |
|